[J01EC01, sulfamethoxazole, Pravastatin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[M04AB02, sulfinpyrazone, Pravastatin may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.]
[L01BB02, mercaptopurine, The excretion of Mercaptopurine can be decreased when combined with Pravastatin.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Tacrine.]
[L02BA01, tamoxifen, Tamoxifen may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01CB02, teniposide, Pravastatin may decrease the excretion rate of Teniposide which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Pravastatin.]
[G03BA03, testosterone, Pravastatin may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[S03AA02, tetracycline, The excretion of Tetracycline can be decreased when combined with Pravastatin.]
[P01AB02, tinidazole, Pravastatin may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Triamcinolone.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Triazolam.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Pravastatin.]
[J01EA01, trimethoprim, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Trimethoprim.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Pravastatin.]
[L01EX04, vandetanib, Vandetanib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[A10BH05, linagliptin, The serum concentration of Pravastatin can be increased when it is combined with Linagliptin.]
[J05AP03, boceprevir, The serum concentration of Pravastatin can be increased when it is combined with Boceprevir.]
[J05AP02, telaprevir, The serum concentration of Pravastatin can be increased when it is combined with Telaprevir.]
[J05AG05, rilpivirine, Rilpivirine may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[B01AF01, rivaroxaban, Pravastatin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, The serum concentration of Indacaterol can be increased when it is combined with Pravastatin.]
[B01AC24, ticagrelor, The serum concentration of Pravastatin can be increased when it is combined with Ticagrelor.]
[C08DA01, verapamil, The serum concentration of Pravastatin can be increased when it is combined with Verapamil.]
[L01CA01, vinblastine, Vinblastine may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01CA02, vincristine, Pravastatin may decrease the excretion rate of Vincristine which could result in a higher serum level.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Pravastatin is combined with Warfarin.]
[J05AF01, zidovudine, The excretion of Zidovudine can be decreased when combined with Pravastatin.]
[J05AE02, indinavir, Pravastatin may decrease the excretion rate of Indinavir which could result in a higher serum level.]
[L01EC01, vemurafenib, The serum concentration of Pravastatin can be increased when it is combined with Vemurafenib.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Pamidronic acid.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be increased when it is combined with Pravastatin.]
[L01ED01, crizotinib, The serum concentration of Pravastatin can be increased when it is combined with Crizotinib.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Ibandronate.]
[N02BA01, aspirin, The excretion of Pravastatin can be decreased when combined with Acetylsalicylic acid.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Pravastatin.]
[C07AB03, atenolol, Pravastatin may decrease the excretion rate of Atenolol which could result in a higher serum level.]
[S01FA01, atropine, Pravastatin may decrease the excretion rate of Atropine which could result in a higher serum level.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01EK01, axitinib, The serum concentration of Axitinib can be increased when it is combined with Pravastatin.]
[R07AX02, ivacaftor, The serum concentration of Pravastatin can be increased when it is combined with Ivacaftor.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Pravastatin.]
[G04BE10, avanafil, Avanafil may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Baclofen.]
[G04BD12, mirabegron, The serum concentration of Pravastatin can be increased when it is combined with Mirabegron.]
[L01XG02, carfilzomib, The serum concentration of Pravastatin can be increased when it is combined with Carfilzomib.]
[V03AX03, cobicistat, Cobicistat may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Pravastatin.]
[L04AA31, teriflunomide, The excretion of Pravastatin can be decreased when combined with Teriflunomide.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[J05AE04, nelfinavir, The serum concentration of Pravastatin can be decreased when it is combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Pravastatin.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Lercanidipine.]
[N06DA02, donepezil, Pravastatin may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[G04BE03, sildenafil, The serum concentration of Pravastatin can be increased when it is combined with Sildenafil.]
[L01EA05, ponatinib, Pravastatin may decrease the excretion rate of Ponatinib which could result in a higher serum level.]
[B01AF02, apixaban, Pravastatin may decrease the excretion rate of Apixaban which could result in a higher serum level.]
[C10AX12, lomitapide, The serum concentration of Pravastatin can be increased when it is combined with Lomitapide.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Pravastatin.]
[A10BK02, canagliflozin, The serum concentration of Pravastatin can be increased when it is combined with Canagliflozin.]
[M04AB03, benzbromarone, Pravastatin may decrease the excretion rate of Benzbromarone which could result in a higher serum level.]
[A06AX06, tegaserod, Pravastatin may decrease the excretion rate of Tegaserod which could result in a higher serum level.]
[J02AX04, caspofungin, The excretion of Pravastatin can be decreased when combined with Caspofungin.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[C10AC04, colesevelam, Colesevelam can cause a decrease in the absorption of Pravastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA18, everolimus, The serum concentration of Pravastatin can be increased when it is combined with Everolimus.]
[L01EC02, dabrafenib, The excretion of Pravastatin can be decreased when combined with Dabrafenib.]
[L01EB03, afatinib, Pravastatin may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[J05AJ03, dolutegravir, The excretion of Pravastatin can be decreased when combined with Dolutegravir.]
[C02KX05, riociguat, Pravastatin may decrease the excretion rate of Riociguat which could result in a higher serum level.]
[A05AA03, cholic acid, Cholic Acid may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[J05AP05, simeprevir, The serum concentration of Pravastatin can be increased when it is combined with Simeprevir.]
[J05AP08, sofosbuvir, Pravastatin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Betamethasone.]
[C10AB02, bezafibrate, Bezafibrate may increase the myopathic rhabdomyolysis activities of Pravastatin.]
[L01ED02, ceritinib, The serum concentration of Ceritinib can be increased when it is combined with Pravastatin.]
[B01AC26, vorapaxar, The serum concentration of Pravastatin can be increased when it is combined with Vorapaxar.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Pravastatin is combined with Acenocoumarol.]
[L01XH04, belinostat, The serum concentration of Belinostat can be increased when it is combined with Pravastatin.]
[L01EM01, idelalisib, Pravastatin may decrease the excretion rate of Idelalisib which could result in a higher serum level.]
[N07XX08, tafamidis, The serum concentration of Pravastatin can be increased when it is combined with Tafamidis.]
[N05CM19, suvorexant, The serum concentration of Pravastatin can be increased when it is combined with Suvorexant.]
[A16AX10, eliglustat, The serum concentration of Pravastatin can be increased when it is combined with Eliglustat.]
[L01EX09, nintedanib, The serum concentration of Nintedanib can be increased when it is combined with Pravastatin.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Pravastatin is combined with Dicoumarol.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Pravastatin.]
[L01EF01, palbociclib, Pravastatin may decrease the excretion rate of Palbociclib which could result in a higher serum level.]
[L01EX08, lenvatinib, Lenvatinib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be increased when it is combined with Pravastatin.]
[J05AP07, daclatasvir, The serum concentration of Pravastatin can be increased when it is combined with Daclatasvir.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Pravastatin is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, The excretion of Adefovir dipivoxil can be decreased when combined with Pravastatin.]
[J05AP06, asunaprevir, The serum concentration of Pravastatin can be increased when it is combined with Asunaprevir.]
[A07DA06, eluxadoline, The excretion of Eluxadoline can be decreased when combined with Pravastatin.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[G02CX02, flibanserin, The serum concentration of Pravastatin can be increased when it is combined with Flibanserin.]
[C10AD06, acipimox, Acipimox may increase the myopathic rhabdomyolysis activities of Pravastatin.]
[A02BC03, lansoprazole, The excretion of Pravastatin can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The risk or severity of myopathy and rhabdomyolysis can be increased when Pravastatin is combined with Trabectedin.]
[J02AC05, isavuconazole, The serum concentration of Pravastatin can be increased when it is combined with Isavuconazole.]
[L01EB04, osimertinib, Pravastatin may decrease the excretion rate of Osimertinib which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Pravastatin.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Pravastatin.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[B01AC27, selexipag, The serum concentration of Selexipag can be increased when it is combined with Pravastatin.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01XX52, venetoclax, Pravastatin may decrease the excretion rate of Venetoclax which could result in a higher serum level.]
[C03CA02, bumetanide, The excretion of Bumetanide can be decreased when combined with Pravastatin.]
[N07BC01, buprenorphine, Buprenorphine may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01XX27, arsenic trioxide, The serum concentration of Pravastatin can be increased when it is combined with Arsenic trioxide.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01XK03, rucaparib, Pravastatin may decrease the excretion rate of Rucaparib which could result in a higher serum level.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[J01XX08, linezolid, The excretion of Pravastatin can be decreased when combined with Linezolid.]
[J05AE09, tipranavir, Tipranavir may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L04AB02, infliximab, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Pravastatin.]
[L01ED04, brigatinib, Pravastatin may decrease the excretion rate of Brigatinib which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[J01MA23, delafloxacin, Pravastatin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Pravastatin.]
[L01XX59, enasidenib, The excretion of Pravastatin can be decreased when combined with Enasidenib.]
[L01EH02, neratinib, The serum concentration of Pravastatin can be increased when it is combined with Neratinib.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Pravastatin.]
[L01EM02, copanlisib, Pravastatin may decrease the excretion rate of Copanlisib which could result in a higher serum level.]
[L01EF03, abemaciclib, Pravastatin may decrease the excretion rate of Abemaciclib which could result in a higher serum level.]
[C07AB07, bisoprolol, The serum concentration of Bisoprolol can be increased when it is combined with Pravastatin.]
[J05AG03, efavirenz, The serum concentration of Pravastatin can be decreased when it is combined with Efavirenz.]
[V03AB23, acetylcysteine, The excretion of Pravastatin can be decreased when combined with Acetylcysteine.]
[R03BA02, budesonide, Pravastatin may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[A10BK04, ertugliflozin, Pravastatin may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Pravastatin.]
[L02BB05, apalutamide, The serum concentration of Pravastatin can be decreased when it is combined with Apalutamide.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Carbimazole.]
[C07AG02, carvedilol, The serum concentration of Pravastatin can be increased when it is combined with Carvedilol.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[B02BX08, avatrombopag, The excretion of Pravastatin can be decreased when combined with Avatrombopag.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Pravastatin.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Pravastatin.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Pravastatin.]
[H01CC03, elagolix, The serum concentration of Pravastatin can be increased when it is combined with Elagolix.]
[N03AX17, stiripentol, The excretion of Pravastatin can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Pravastatin may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[L01EM04, duvelisib, Pravastatin may decrease the excretion rate of Duvelisib which could result in a higher serum level.]
[L01EB07, dacomitinib, Pravastatin may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[J01AA14, sarecycline, The serum concentration of Pravastatin can be increased when it is combined with Sarecycline.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Pravastatin.]
[L01XK04, talazoparib, Pravastatin may decrease the excretion rate of Talazoparib which could result in a higher serum level.]
[R03BB08, revefenacin, Pravastatin may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01EX12, larotrectinib, The serum concentration of Larotrectinib can be increased when it is combined with Pravastatin.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01XJ03, glasdegib, Pravastatin may decrease the excretion rate of Glasdegib which could result in a higher serum level.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofibrate is combined with Pravastatin.]
[J01FA09, clarithromycin, The serum concentration of Pravastatin can be increased when it is combined with Clarithromycin.]
[L01EN01, erdafitinib, The serum concentration of Pravastatin can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, The serum concentration of Clobazam can be increased when it is combined with Pravastatin.]
[C01EB09, ubidecarenone, The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Pravastatin.]
[C09CA06, candesartan, The excretion of Pravastatin can be decreased when combined with Candesartan.]
[V03AE02, sevelamer, Sevelamer can cause a decrease in the absorption of Pravastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Pravastatin.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Pravastatin.]
[J01DB05, cefadroxil, The excretion of Pravastatin can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Pravastatin can be decreased when combined with Cefamandole.]
[L01XX66, selinexor, The excretion of Pravastatin can be decreased when combined with Selinexor.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Pravastatin.]
[L02BB06, darolutamide, The serum concentration of Pravastatin can be increased when it is combined with Darolutamide.]
[L01EX15, pexidartinib, The excretion of Pravastatin can be decreased when combined with Pexidartinib.]
[J01DD12, cefoperazone, The excretion of Pravastatin can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Pravastatin can be decreased when combined with Cefotaxime.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Pravastatin.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Pravastatin.]
[J01DD04, ceftriaxone, The excretion of Pravastatin can be decreased when combined with Ceftriaxone.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01EX14, entrectinib, The serum concentration of Pravastatin can be increased when it is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Pravastatin can be increased when it is combined with Pitolisant.]
[J01XX12, lefamulin, The serum concentration of Lefamulin can be increased when it is combined with Pravastatin.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[J01XX09, daptomycin, The risk or severity of myopathy can be increased when Pravastatin is combined with Daptomycin.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Pravastatin.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Pravastatin.]
[J01DB03, cephalothin, The excretion of Pravastatin can be decreased when combined with Cefalotin.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be increased when it is combined with Pravastatin.]
[N02CC08, lasmiditan, The serum concentration of Pravastatin can be increased when it is combined with Lasmiditan.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Pravastatin.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Pravastatin.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Pravastatin.]
[L01XX72, tazemetostat, Pravastatin may decrease the excretion rate of Tazemetostat which could result in a higher serum level.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Pravastatin.]
[C10AX15, bempedoic acid, The risk or severity of myopathy can be increased when Bempedoic acid is combined with Pravastatin.]
[J05AB16, remdesivir, The excretion of Pravastatin can be decreased when combined with Remdesivir.]
[J05AE05, amprenavir, The excretion of Pravastatin can be decreased when combined with Amprenavir.]
[L04AA38, ozanimod, Pravastatin may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, Pravastatin may decrease the excretion rate of Selumetinib which could result in a higher serum level.]
[C01BD07, dronedarone, The serum concentration of Pravastatin can be increased when it is combined with Dronedarone.]
[V03AE03, lanthanum carbonate, The absorption of Pravastatin can be decreased when combined with Lanthanum carbonate.]
[L01EH03, tucatinib, Tucatinib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01EX17, capmatinib, The serum concentration of Pravastatin can be increased when it is combined with Capmatinib.]
[L01EX19, ripretinib, Pravastatin may decrease the excretion rate of Ripretinib which could result in a higher serum level.]
[J05AX29, fostemsavir, The serum concentration of Pravastatin can be increased when it is combined with Fostemsavir.]
[L01FX15, belantamab mafodotin, Pravastatin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Chloroquine.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[V04CK02, cholecystokinin, The excretion of Pravastatin can be decreased when combined with Cholecystokinin.]
[C10AC01, cholestyramine resin, Cholestyramine can cause a decrease in the absorption of Pravastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C10AB09, etofibrate, The risk or severity of myopathy and rhabdomyolysis can be increased when Etofibrate is combined with Pravastatin.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Pravastatin.]
[A16AX20, lonafarnib, The serum concentration of Pravastatin can be increased when it is combined with Lonafarnib.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Pravastatin.]
[J05AJ04, cabotegravir, The excretion of Pravastatin can be decreased when combined with Cabotegravir.]
[L04AD03, voclosporin, The serum concentration of Pravastatin can be increased when it is combined with Voclosporin.]
[L01EX21, tepotinib, The serum concentration of Pravastatin can be increased when it is combined with Tepotinib.]
[L01EX25, umbralisib, The serum concentration of Pravastatin can be increased when it is combined with Umbralisib.]
[V03AF12, trilaciclib, Pravastatin may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Pravastatin.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Pravastatin.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Pravastatin.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01XX73, sotorasib, The serum concentration of Pravastatin can be increased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Ciprofloxacin.]
[L04AA48, belumosudil, Belumosudil may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[P01CA03, fexinidazole, The excretion of Pravastatin can be decreased when combined with Fexinidazole.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Pravastatin.]
[A10BB12, glimepiride, Pravastatin may decrease the excretion rate of Glimepiride which could result in a higher serum level.]
[L01EA06, asciminib, The serum concentration of Pravastatin can be increased when it is combined with Asciminib.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[D11AH08, abrocitinib, The serum concentration of Pravastatin can be increased when it is combined with Abrocitinib.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[C10AB01, clofibrate, The risk or severity of myopathy and rhabdomyolysis can be increased when Clofibrate is combined with Pravastatin.]
[B06AX04, mitapivat, The serum concentration of Pravastatin can be increased when it is combined with Mitapivat.]
[L01EJ03, pacritinib, The serum concentration of Pravastatin can be increased when it is combined with Pacritinib.]
[G03GB02, clomiphene, The serum concentration of Clomifene can be increased when it is combined with Pravastatin.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Pravastatin.]
[J02AC06, oteseconazole, The serum concentration of Pravastatin can be increased when it is combined with Oteseconazole.]
[A05BA08, glycyrrhizic acid, Pravastatin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be increased when it is combined with Pravastatin.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[M04AC01, colchicine, Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.]
[C10AC02, colestipol, Colestipol can cause a decrease in the absorption of Pravastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA13, leflunomide, Pravastatin may decrease the excretion rate of Leflunomide which could result in a higher serum level.]
[J01FA15, telithromycin, The serum concentration of Pravastatin can be increased when it is combined with Telithromycin.]
[J02AC02, itraconazole, Itraconazole may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[S01AD03, acyclovir, The excretion of Acyclovir can be decreased when combined with Pravastatin.]
[L01EA01, imatinib, Pravastatin may decrease the excretion rate of Imatinib which could result in a higher serum level.]
[J02AC04, posaconazole, The serum concentration of Posaconazole can be increased when it is combined with Pravastatin.]
[A02BC05, esomeprazole, The excretion of Pravastatin can be decreased when combined with Esomeprazole.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Nafarelin.]
[R06AX13, loratadine, Pravastatin may decrease the excretion rate of Loratadine which could result in a higher serum level.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Mebeverine.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Pravastatin.]
[S01XA18, cyclosporine, The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.]
[C10AA07, rosuvastatin, The excretion of Rosuvastatin can be decreased when combined with Pravastatin.]
[C03XA02, conivaptan, The serum concentration of Pravastatin can be increased when it is combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Cytarabine.]
[G04BE09, vardenafil, The serum concentration of Pravastatin can be increased when it is combined with Vardenafil.]
[L01DA01, dactinomycin, Pravastatin may decrease the excretion rate of Dactinomycin which could result in a higher serum level.]
[G03XA01, danazol, The serum concentration of Pravastatin can be increased when it is combined with Danazol.]
[L01DB02, daunorubicin, Pravastatin may decrease the excretion rate of Daunorubicin which could result in a higher serum level.]
[N06AX06, nefazodone, Pravastatin may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[L01XA03, oxaliplatin, Pravastatin may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.]
[S03BA01, dexamethasone, The excretion of Dexamethasone can be decreased when combined with Pravastatin.]
[L01EB01, gefitinib, Pravastatin may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[N06AB05, paroxetine, The risk or severity of increased glucose can be increased when Pravastatin is combined with Paroxetine.]
[S01BC03, diclofenac, The excretion of Pravastatin can be decreased when combined with Diclofenac.]
[J05AF03, zalcitabine, The excretion of Zalcitabine can be decreased when combined with Pravastatin.]
[J05AF02, didanosine, The excretion of Didanosine can be decreased when combined with Pravastatin.]
[L01DC04, ixabepilone, The serum concentration of Pravastatin can be increased when it is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Pravastatin can be decreased when combined with Erlotinib.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[C08CA03, isradipine, Pravastatin may decrease the excretion rate of Isradipine which could result in a higher serum level.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Pravastatin.]
[C01AA05, digoxin, Pravastatin may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C10AX09, ezetimibe, Pravastatin may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[C04AE04, dihydroergocristine, Pravastatin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level.]
[J05AE08, atazanavir, Pravastatin may decrease the excretion rate of Atazanavir which could result in a higher serum level.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Pravastatin.]
[C05CA03, diosmin, The serum concentration of Pravastatin can be increased when it is combined with Diosmin.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Pravastatin.]
[B01AC07, dipyridamole, Pravastatin may decrease the excretion rate of Dipyridamole which could result in a higher serum level.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be increased when it is combined with Pravastatin.]
[P03AA04, disulfiram, Pravastatin may decrease the excretion rate of Disulfiram which could result in a higher serum level.]
[S02AA12, rifamycin SV, The serum concentration of Pravastatin can be increased when it is combined with Rifamycin.]
[N07XX02, riluzole, Pravastatin may decrease the excretion rate of Riluzole which could result in a higher serum level.]
[L01EX01, sunitinib, Sunitinib may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be increased when it is combined with Pravastatin.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Pravastatin.]
[C02KX02, ambrisentan, The serum concentration of Ambrisentan can be increased when it is combined with Pravastatin.]
[C01EB18, ranolazine, The serum concentration of Pravastatin can be increased when it is combined with Ranolazine.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Salmeterol.]
[L01DB01, doxorubicin, Pravastatin may decrease the excretion rate of Doxorubicin which could result in a higher serum level.]
[C10AA01, simvastatin, The serum concentration of Pravastatin can be increased when it is combined with Simvastatin.]
[N02CC01, sumatriptan, Pravastatin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[C07AB13, talinolol, The serum concentration of Talinolol can be increased when it is combined with Pravastatin.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Pravastatin.]
[M01AC02, tenoxicam, The excretion of Pravastatin can be decreased when combined with Tenoxicam.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Terbinafine.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Emetine.]
[N06AX14, tianeptine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Tianeptine.]
[C09AA02, enalapril, The excretion of Pravastatin can be decreased when combined with Enalapril.]
[L02BA02, toremifene, The serum concentration of Pravastatin can be increased when it is combined with Toremifene.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Pravastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX15, zonisamide, The serum concentration of Pravastatin can be increased when it is combined with Zonisamide.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Iloprost.]
[N03AG01, valproic acid, The excretion of Valproic acid can be decreased when combined with Pravastatin.]
[S01AA17, erythromycin, The risk or severity of myopathy and rhabdomyolysis can be increased when Erythromycin is combined with Pravastatin.]
[A02BC02, pantoprazole, The excretion of Pravastatin can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, The excretion of Estradiol can be decreased when combined with Pravastatin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Pravastatin.]
[R03BA05, fluticasone, The excretion of Pravastatin can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, Ethinylestradiol may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01CB01, etoposide, Pravastatin may decrease the excretion rate of Etoposide which could result in a higher serum level.]
[L04AD02, tacrolimus, The serum concentration of Pravastatin can be increased when it is combined with Tacrolimus.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Nizatidine.]
[R06AX11, astemizole, Pravastatin may decrease the excretion rate of Astemizole which could result in a higher serum level.]
[R06AX12, terfenadine, Pravastatin may decrease the excretion rate of Terfenadine which could result in a higher serum level.]
[N06AB08, fluvoxamine, Pravastatin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Pravastatin.]
[S01AA13, fusidic acid, The risk or severity of rhabdomyolysis can be increased when Fusidic acid is combined with Pravastatin.]
[R03BA09, fluticasone furoate, The excretion of Pravastatin can be decreased when combined with Fluticasone furoate.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Pravastatin.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Pravastatin.]
[C08CA02, felodipine, Pravastatin may decrease the excretion rate of Felodipine which could result in a higher serum level.]
[L01BB06, clofarabine, The excretion of Clofarabine can be decreased when combined with Pravastatin.]
[L04AA40, cladribine, Pravastatin may decrease the excretion rate of Cladribine which could result in a higher serum level.]
[J01CF05, floxacillin, Pravastatin may decrease the excretion rate of Flucloxacillin which could result in a higher serum level.]
[J02AC01, fluconazole, The serum concentration of Pravastatin can be increased when it is combined with Fluconazole.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Ethanol.]
[L01BC02, fluorouracil, Pravastatin may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[V04CX02, folic acid, Pravastatin may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[J05AE10, darunavir, The serum concentration of Pravastatin can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, The excretion of Pravastatin can be decreased when combined with Furosemide.]
[S01AD09, ganciclovir, The excretion of Pravastatin can be decreased when combined with Ganciclovir.]
[C10AB04, gemfibrozil, The risk or severity of rhabdomyolysis, myoglobinuria, and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.]
[L01EA02, dasatinib, Pravastatin may decrease the excretion rate of Dasatinib which could result in a higher serum level.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be increased when it is combined with Pravastatin.]
[L01EH01, lapatinib, The serum concentration of Pravastatin can be increased when it is combined with Lapatinib.]
[A10BB01, glyburide, Glyburide may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[A10BB07, glipizide, Pravastatin may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[L01EX02, sorafenib, Pravastatin may decrease the excretion rate of Sorafenib which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Pravastatin is combined with Fluindione.]
[L01CE02, irinotecan, Pravastatin may decrease the excretion rate of Irinotecan which could result in a higher serum level.]
[M04AA01, allopurinol, The excretion of Allopurinol can be decreased when combined with Pravastatin.]
[C09CA01, losartan, Pravastatin may decrease the excretion rate of Losartan which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Pravastatin.]
[S02BA01, hydrocortisone, The excretion of Hydrocortisone can be decreased when combined with Pravastatin.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Risedronic acid.]
[R02AX02, ibuprofen, The excretion of Pravastatin can be decreased when combined with Ibuprofen.]
[N06AA02, imipramine, The serum concentration of Imipramine can be increased when it is combined with Pravastatin.]
[L01CD01, paclitaxel, Paclitaxel may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01CE01, topotecan, Pravastatin may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[S01BC01, indomethacin, The excretion of Indomethacin can be decreased when combined with Pravastatin.]
[A10BH01, sitagliptin, The excretion of Sitagliptin can be decreased when combined with Pravastatin.]
[C10AA06, cerivastatin, Pravastatin may decrease the excretion rate of Cerivastatin which could result in a higher serum level.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Ipecac.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Stavudine.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Pravastatin.]
[J04AC01, isoniazid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Isoniazid.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Isotretinoin.]
[P02CF01, ivermectin, Pravastatin may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pravastatin.]
[J02AB02, ketoconazole, Ketoconazole may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[M02AA10, ketoprofen, The excretion of Pravastatin can be decreased when combined with Ketoprofen.]
[A07DA03, loperamide, The serum concentration of Loperamide can be increased when it is combined with Pravastatin.]
[C10AA02, lovastatin, Pravastatin may decrease the excretion rate of Lovastatin which could result in a higher serum level.]
[N05AH01, loxapine, The serum concentration of Pravastatin can be increased when it is combined with Loxapine.]
[L01EG01, temsirolimus, The serum concentration of Pravastatin can be increased when it is combined with Temsirolimus.]
[L01BA05, pralatrexate, Pravastatin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, Pravastatin may decrease the excretion rate of Nilotinib which could result in a higher serum level.]
[V04CX04, mannitol, The serum concentration of Mannitol can be increased when it is combined with Pravastatin.]
[P01BC02, mefloquine, The serum concentration of Pravastatin can be increased when it is combined with Mefloquine.]
[N05CH01, melatonin, The excretion of Pravastatin can be decreased when combined with Melatonin.]
[N05AX13, paliperidone, The serum concentration of Pravastatin can be increased when it is combined with Paliperidone.]
[A10BA02, metformin, Metformin may increase the hypolipidaemic activities of Pravastatin.]
[J05AF05, lamivudine, Pravastatin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01BA04, pemetrexed, Pravastatin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[L04AX03, methotrexate, The excretion of Methotrexate can be decreased when combined with Pravastatin.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Methyldopa.]
[V04CG05, methylene blue, The serum concentration of Pravastatin can be increased when it is combined with Methylene blue.]
[G03EK01, methyltestosterone, The excretion of Pravastatin can be increased when combined with Methyltestosterone.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Metoclopramide.]
[G03XB01, mifepristone, The serum concentration of Pravastatin can be increased when it is combined with Mifepristone.]
[C09CA03, valsartan, The excretion of Pravastatin can be decreased when combined with Valsartan.]
[J01AA08, minocycline, The excretion of Pravastatin can be decreased when combined with Minocycline.]
[L01DB07, mitoxantrone, Pravastatin may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.]
[C01BD01, amiodarone, The metabolism of Pravastatin can be increased when combined with Amiodarone.]
[N02AA01, morphine, The serum concentration of Morphine can be increased when it is combined with Pravastatin.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01EX03, pazopanib, Pravastatin may increase the hepatotoxic activities of Pazopanib.]
[J05AJ01, raltegravir, The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Pravastatin.]
[G04CA04, silodosin, The serum concentration of Silodosin can be increased when it is combined with Pravastatin.]
[G03XC01, raloxifene, Pravastatin may decrease the excretion rate of Raloxifene which could result in a higher serum level.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Naltrexone.]
[M02AA12, naproxen, Pravastatin may decrease the excretion rate of Naproxen which could result in a higher serum level.]
[A10BG01, troglitazone, Troglitazone may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[L01CD02, docetaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Docetaxel.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Letrozole.]
[A10BX02, repaglinide, Pravastatin may decrease the excretion rate of Repaglinide which could result in a higher serum level.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Amphotericin B.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[J05AB11, valacyclovir, The excretion of Valaciclovir can be decreased when combined with Pravastatin.]
[M04AA03, febuxostat, The excretion of Pravastatin can be decreased when combined with Febuxostat.]
[C10AD02, niacin, The risk or severity of myopathy and rhabdomyolysis can be increased when Niacin is combined with Pravastatin.]
[C08CA04, nicardipine, Pravastatin may decrease the excretion rate of Nicardipine which could result in a higher serum level.]
[C08CA05, nifedipine, Pravastatin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C08CA08, nitrendipine, Pravastatin may decrease the excretion rate of Nitrendipine which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Pravastatin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Norfloxacin.]
[C02KX01, bosentan, The serum concentration of Pravastatin can be decreased when it is combined with Bosentan.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be increased when it is combined with Pravastatin.]
[A16AX07, sapropterin, The serum concentration of Pravastatin can be increased when it is combined with Sapropterin.]
[G01AA01, nystatin, The excretion of Pravastatin can be decreased when combined with Nystatin.]
[S02AA16, ofloxacin, Pravastatin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[C01AC01, ouabain, The excretion of Pravastatin can be decreased when combined with Ouabain.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Pravastatin.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Pravastatin.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Penicillamine.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Pravastatin.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Pravastatin is combined with Phenindione.]
[N03AA02, phenobarbital, Phenobarbital may increase the excretion rate of Pravastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Pravastatin is combined with Phenprocoumon.]
[M02AA01, phenylbutazone, The excretion of Pravastatin can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Phenytoin.]
[S01AE05, levofloxacin, The excretion of Levofloxacin can be decreased when combined with Pravastatin.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Pravastatin.]
[J05AB12, cidofovir, The excretion of Cidofovir can be decreased when combined with Pravastatin.]
[C08CX01, mibefradil, The serum concentration of Pravastatin can be increased when it is combined with Mibefradil.]
[C10AA05, atorvastatin, Pravastatin may decrease the excretion rate of Atorvastatin which could result in a higher serum level.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Pravastatin.]
[J05AE01, saquinavir, The serum concentration of Pravastatin can be decreased when it is combined with Saquinavir.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Eprosartan.]
[S01BC06, piroxicam, The excretion of Pravastatin can be decreased when combined with Piroxicam.]
[J01MA11, grepafloxacin, The excretion of Grepafloxacin can be decreased when combined with Pravastatin.]
[A10BG02, rosiglitazone, Pravastatin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Pravastatin.]
[J05AE03, ritonavir, Ritonavir may increase the myopathic rhabdomyolysis activities of Pravastatin.]
[A10BH03, saxagliptin, The excretion of Saxagliptin can be decreased when combined with Pravastatin.]
[C10AA08, pitavastatin, Pravastatin may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[C02CA01, prazosin, Pravastatin may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[M04AB01, probenecid, The excretion of Pravastatin can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Procainamide.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Procarbazine.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[C01BC03, propafenone, The serum concentration of Pravastatin can be increased when it is combined with Propafenone.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Pravastatin.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be increased when it is combined with Pravastatin.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Propofol.]
[C07AA05, propranolol, The metabolism of Pravastatin can be increased when combined with Propranolol.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Propylthiouracil.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Montelukast.]
[C01BA01, quinidine, Quinidine may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[P01BC01, quinine, The serum concentration of Pravastatin can be increased when it is combined with Quinine.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Pravastatin.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[J04AB02, rifampin, Rifampicin may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[J01FA06, roxithromycin, The excretion of Pravastatin can be decreased when combined with Roxithromycin.]
[A07EC01, sulfasalazine, Pravastatin may decrease the excretion rate of Sulfasalazine which could result in a higher serum level.]
[S01BC08, salicylic acid, The excretion of Pravastatin can be decreased when combined with Salicylic acid.]
[L01CD04, cabazitaxel, Cabazitaxel may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[C03DA01, spironolactone, Pravastatin may decrease the excretion rate of Spironolactone which could result in a higher serum level.]
[D11AX24, deoxycholic acid, Deoxycholic acid may increase the excretion rate of Pravastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Alendronic acid.]
[H02CA04, levoketoconazole, The serum concentration of Pravastatin can be increased when it is combined with Levoketoconazole.]
[A05AA02, ursodiol, Ursodeoxycholic acid may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
